FDA Inspection 884918 — Institute for Reproductive Health

Institute for Reproductive Health — FEI 3004562849

The FDA completed an inspection of Institute for Reproductive Health on June 24, 2014 in Cincinnati, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 24, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Cincinnati, OH (United States)